Zhi Cheng Selected Research

bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine

12/2023	An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously.
1/2022	Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literature.
1/2022	CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi Cheng Research Topics

Disease

9	Neoplasms (Cancer) 03/2024 - 06/2008
9	Head and Neck Neoplasms (Head and Neck Cancer) 08/2021 - 12/2017
5	Enterocolitis 01/2019 - 02/2011
4	Multiple Myeloma 12/2023 - 04/2020
4	COVID-19 11/2023 - 01/2022
4	Xerostomia 03/2020 - 01/2019
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 08/2017
3	Weight Loss (Weight Reduction) 07/2020 - 07/2018
2	Pain (Aches) 03/2024 - 06/2014
2	Inflammation (Inflammations) 03/2023 - 01/2022
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2019 - 12/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 10/2018
2	Deglutition Disorders (Dysphagia) 01/2018 - 12/2017
2	Lymphopenia (Lymphocytopenia) 03/2015 - 02/2011
1	Colorectal Neoplasms (Colorectal Cancer) 04/2024
1	Neuralgia (Stump Neuralgia) 03/2024
1	Dyskinesias (Dyskinesia) 02/2024
1	Disease Progression 12/2023
1	Chronic Disease (Chronic Diseases) 12/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Vertigo (Positional Vertigo) 01/2023
1	Cough 01/2022
1	Cough-Variant Asthma 01/2022
1	Oropharyngeal Neoplasms 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Citrullinemia 01/2022
1	Dermatitis 08/2021
1	Adenocarcinoma 03/2021
1	Cardiomegaly (Heart Hypertrophy) 11/2020
1	Lung Neoplasms (Lung Cancer) 07/2020
1	Mental Disorders (Mental Disorder) 08/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Fetomaternal Transfusion 04/2018
1	Choriocarcinoma 04/2018
1	Cognitive Dysfunction 01/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2017
1	Substance-Related Disorders (Drug Abuse) 08/2016
1	Hypertrophy 02/2016
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2016
1	Hirschsprung Disease (Hirschsprung's Disease) 01/2016
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 12/2015
1	Squamous Cell Carcinoma of Head and Neck 06/2014
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 06/2014

Drug/Important Bio-Agent (IBA)

5	U1 small nuclear RNAIBA 01/2021 - 08/2017
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 04/2020 - 12/2015
3	Endothelin Receptors (Endothelin Receptor)IBA 01/2018 - 02/2011
2	Chimeric Antigen ReceptorsIBA 12/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 11/2023 - 08/2019
2	Heparin (Liquaemin)FDA LinkGeneric 03/2022 - 02/2022
2	Polysaccharides (Glycans)IBA 03/2022 - 02/2022
2	Small Nuclear RNA (snRNA)IBA 01/2021 - 08/2017
2	Transcription Factors (Transcription Factor)IBA 02/2016 - 12/2015
1	Epidermal Growth Factor (EGF)IBA 03/2024
1	ZearalenoneIBA 02/2024
1	Caspase 8 (Caspase-8)IBA 02/2024
1	Dietary Fiber FDA Link 12/2023
1	vadimezanIBA 03/2023
1	InterferonsIBA 03/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	Propofol (Diprivan)FDA LinkGeneric 01/2023
1	remimazolamIBA 01/2023
1	Leukotriene C4IBA 01/2022
1	Leukotriene B4IBA 01/2022
1	B-Cell Maturation AntigenIBA 01/2022
1	Immunoglobulin D (IgD)IBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	CitrullineIBA 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	Presenilin-1IBA 01/2021
1	Long Noncoding RNAIBA 11/2020
1	Messenger RNA (mRNA)IBA 04/2020
1	ribonucleotide reductase M2IBA 04/2020
1	Anti-Idiotypic AntibodiesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	AntibodiesIBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	MannansIBA 01/2019
1	Ribonuclease III (RNase III)IBA 01/2019
1	PorinsIBA 01/2019
1	HydrogelsIBA 11/2018
1	AntigensIBA 10/2018
1	CarbohydratesIBA 10/2018
1	Neuroprotective AgentsIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 08/2017
1	CytokinesIBA 02/2017
1	Parathyroid Hormone-Related ProteinIBA 02/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Volatile Fatty AcidsIBA 01/2016
1	Twist-Related Protein 1IBA 12/2015
1	Endothelins (Endothelin)IBA 03/2015

Therapy/Procedure

14	Radiotherapy 03/2024 - 08/2016
9	Therapeutics 12/2023 - 06/2008
4	Drug Therapy (Chemotherapy) 07/2020 - 04/2008
3	Aftercare (After-Treatment) 03/2024 - 12/2017
1	Fluid Therapy (Oral Rehydration Therapy) 04/2024
1	Length of Stay 04/2024
1	Free Tissue Flaps 01/2022
1	Transplantation 01/2022